Markets await more stimulus and COVID-19 vaccine news - Thursday Review, December 3

Markets await more stimulus and COVID-19 vaccine news - Thursday Review, December 3

Markets focused on the COVID-19 vaccine for the third day in a row

The US

The ongoing hope for a new #stimulus package continued to improve investor sentiment. USA30 rose 0.63%, while USA500 went up 0.30%. TECH100 added 0.53%.

Crude Oil settled up 0.6% at $45.64 a barrel.

Gold traded 0.7% higher at $1,842.10 per ounce.

Asia and Australia

The benchmarks closed in the green, driven by the good economic reading that showed the beginning of a post-pandemic rebound. Moreover, the thought of a viable #COVID-19 vaccine boosted the markets.

HongKong45 was up 0.29%.

Japan225 edged up 0.15%.

Down under, Australia200 surged 0.42%.

Europe

The markets stagnated as they were expecting more news about the COVID-19 #vaccine’s approval. Germany30 inched 0.2% lower, while France40 fell 0.3%. UK100 gained 0.1%.

Brent Oil went up almost 1%, trading at $48.71 per barrel.

EUR/USD traded at 1.2117 after it added 0.1%.

Sources: investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.